Ascent Q3 2026 Earnings: Sales Rise 37.8% as Adjusted EBITDA Expands
Ascent Industries reported Q3 2026 net sales of $27.1 million, a 37.8% year-over-year increase, alongside a diluted EPS of $0.15 and adjusted EBITDA of $3.5 million. Growth was driven by volume, pricing, and lower SG&A expenses. However, gross margin contracted 342 basis points to 26.2% due to rising input and shipping costs. The Midwest acquisition added revenue but diluted reported profitability, generating a net loss post-allocations. For the first nine months, operations used $5.5 million in cash, driven by working-capital demands. Key investment risks include margin pressure, integration challenges, and seasonal market conditions. Future performance relies on organic growth and operational execution.
Ascent Industries (Nasdaq: ACNT) reported Q3 2026 net sales from continuing operations of $27.1 million, up 37.8% from $19.7 million, while diluted EPS improved to $0.15 from a loss of $0.01. Adjusted EBITDA rose to $3.5 million from $1.4 million and its margin widened to 13.0%, although gross margin contracted 342 basis points to 26.2%. The Midwest acquisition added revenue but reduced reported net income and adjusted EBITDA after corporate allocations.
Core Earnings Data
Revenue growth was driven by higher volumes and average selling prices. Excluding Midwest, net sales were $24.9 million, representing company-reported growth of 26.3% and showing that most of the quarterly increase came from the existing business rather than the acquisition.
Gross profit increased in dollar terms, but it grew more slowly than revenue. Higher material, labor, overhead, and shipping costs offset part of the benefit from increased production and cost recovery. Lower SG&A expenses helped operating income and adjusted EBITDA improve despite the lower gross margin.
| Metric | Q3 2026 | Q3 2025 | Year-over-Year Change |
|---|---|---|---|
| Net sales | $27.1M | $19.7M | +37.8% |
| Gross profit | $7.1M | $5.8M | +21.9% |
| Gross margin | 26.2% | 29.7% | -342 bps |
| Operating income (loss), continuing operations | $1.6M | ($0.8M) | NM |
| Net income (loss), continuing operations | $1.4M | ($0.1M) | NM |
| Diluted EPS, continuing operations | $0.15 | ($0.01) | NM |
| Adjusted EBITDA | $3.5M | $1.4M | +155.8% |
| Adjusted EBITDA margin | 13.0% | 7.0% | +598 bps |
Adjusted EBITDA is a company-defined non-GAAP measure. NM indicates that the percentage comparison is not meaningful because the prior-year figure was negative.
Business and Segment Performance
Excluding Midwest, gross profit increased 14.1% to $6.7 million. Net income from continuing operations excluding the acquisition was $2.1 million, or $0.23 per diluted share, while adjusted EBITDA was $3.8 million with a 15.1% margin.
Specialty Chemicals adjusted EBITDA increased to $4.1 million from $3.2 million. However, the segment’s adjusted EBITDA margin declined to 14.9% from 16.0%, reinforcing the contrast between higher profit dollars and continued pressure on product-level margins. The stronger consolidated adjusted EBITDA margin was supported by lower corporate expenses, including an approximately 15% reduction in SG&A to $5.3 million.
Midwest Added Revenue but Diluted Reported Profitability
Midwest contributed $2.3 million of Q3 net sales, but it also contributed a $0.7 million net loss and negative adjusted EBITDA of $0.2 million. Consequently, reported sales were higher with the acquisition included, while net income, EPS, and adjusted EBITDA were all stronger when Midwest was excluded.
Management said Midwest remained accretive when corporate allocations were excluded and that the manufacturing transition was on schedule. The key issue for future quarters is whether integration, additional commercial opportunities, and improved operating efficiency can turn the acquisition’s reported contribution positive after allocations.
Profitability, Cash Flow, and the Balance Sheet
The quarter generated positive operating cash flow, according to management, although no quarterly amount was disclosed. For the first nine months of 2026, continuing operations used $5.5 million of operating cash, improving from a $7.6 million outflow in the prior-year period. Working capital remained a significant use of cash, including $8.1 million absorbed by receivables and advances and $1.6 million by inventory, partly offset by a $3.1 million increase in accounts payable.
Cash and cash equivalents were $28.7 million at September 30, down from $57.6 million at the end of 2025. Major nine-month cash uses included $13.6 million for acquisitions, $6.9 million for share repurchases, and $2.3 million for capital expenditures. The company also received the full $4.55 million escrow holdback associated with the sale of certain Bristol Metals assets.
Ascent had no borrowings outstanding under its revolving credit facilities and had $21.1 million of revolver availability. It repurchased no shares during Q3, but bought back 505,563 shares during the first nine months at an average price of $13.29, spending approximately $6.8 million.
Management’s Priorities
Management acknowledged that muted market conditions and seasonality in the legacy business could make improvement uneven. Its operating priorities include standardizing processes, increasing automation where appropriate, improving workflow, and addressing structural costs.
Pricing supported the quarter’s performance, but management expects execution, productivity, and a more efficient operating model to account for a larger share of future margin improvement. That shift will be important because Q3 demonstrated that revenue and gross profit can grow while gross margin remains under pressure.
Recent Insider Transactions
Available insider data show six purchases totaling 27,962 shares and one sale of 1,500 shares over the last six months, resulting in net purchases of 26,462 shares. The latest 10 reported transactions were predominantly stock grants rather than open-market purchases, so the grants should be distinguished from discretionary insider buying.
| Date | Insider | Role | Transaction | Price | Reported Value |
|---|---|---|---|---|---|
| Jun. 26, 2026 | Aldo John Mazzaferro Jr. | Director | Sale of 1,500 shares | $14.10 | $21,150 |
| Jun. 10, 2026 | Benjamin L. Rosenzweig | Director | Stock award | $13.59 | $60,000 |
| Jun. 10, 2026 | Aldo John Mazzaferro Jr. | Director | Stock award | $13.59 | $57,499 |
| Jun. 10, 2026 | Henry L. Guy | Director | Stock award | $13.59 | $65,001 |
| Jun. 10, 2026 | Christopher Gerald Hutter | Director | Stock award | $13.59 | $57,499 |
| Jun. 10, 2026 | Jeremy Rohen | Director | Stock award | $13.59 | $65,001 |
| Jun. 10, 2026 | Carmen Joseph Giannantonio | Director | Stock award | $13.59 | $75,003 |
| Apr. 1, 2026 | Jeremy Rohen | Director | Stock award | $13.32 | $28,747 |
| Apr. 1, 2026 | Carmen Joseph Giannantonio | Director | Stock award | $13.32 | $12,995 |
| Mar. 26, 2026 | Anthony X. Pan | Divisional Officer | Stock award | $12.84 | $64,560 |
All 10 transactions were reported as direct ownership. Total insider holdings were approximately 760,400 shares in the supplied data.
Risks Investors Should Monitor
- Gross margin pressure: Gross margin declined 342 basis points even as sales rose 37.8%, reflecting higher material, labor, overhead, and shipping costs.
- Midwest integration: The acquisition added revenue but produced a net loss and negative adjusted EBITDA after corporate allocations during its first full quarter under Ascent.
- Working-capital demands: Positive quarterly operating cash flow marked progress, but continuing operations still used $5.5 million over the first nine months as receivables and inventory absorbed cash.
- Seasonality and market conditions: Management cited built-in seasonality in the legacy business and muted markets, which could make earnings and cash-flow improvement less consistent.
Summary
Ascent’s Q3 2026 results combined substantial sales growth, a return to positive continuing-operations earnings, and a sharp improvement in adjusted EBITDA. Higher volume, pricing, and lower SG&A drove the progress, while input costs and Midwest’s reported losses limited margin quality. Future results will depend on sustaining organic growth, converting Midwest’s contribution into positive profitability after allocations, and turning the quarterly cash-flow improvement into a consistent trend.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles









Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.